Form 4 for CALC CalciMedica, Inc.

Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001209191-23-020679 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-03-22	2023-03-20	CALC	Stauderman Kenneth A.	CSO	A - Grant	—	+11.9K	11.9K	New	—
DM	2023-03-22	2023-03-20	CALC	Stauderman Kenneth A.	CSO	A - Grant	—	+111.8K	2,090	New	—

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-20	A	A	11,944	—	11,944	D	—	—	(F1) Received in exchange for 414,706 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
2	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	22,777	—	22,777	D	$2.44 · — to 2028-08-01	22,777 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F3) Received in exchange for a stock option to acquire 790,880 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
3	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	8,640	—	8,640	D	$2.44 · — to 2029-04-24	8,640 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F5) Received in exchange for a stock option to acquire 300,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
4	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	1,877	—	1,877	D	$17.34 · — to 2023-03-19	1,877 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F17) Received in exchange for a stock option to acquire 65,191 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F14) Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
5	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	18,991	—	18,991	D	$17.34 · — to 2033-03-19	18,991 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F16) Received in exchange for a stock option to acquire 659,413 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F14) Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
6	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	21,647	—	21,647	D	$6.60 · — to 2030-06-29	21,647 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F7) Received in exchange for a stock option to acquire 751,649 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F6) 25% of the shares subject to the option vested on June 30, 2020 and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments thereafter.
7	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	7,264	—	7,264	D	$7.99 · — to 2031-04-27	7,264 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F9) Received in exchange for a stock option to acquire 252,226 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F8) Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
8	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	13,147	—	13,147	D	$7.99 · — to 2031-04-27	13,147 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F10) Received in exchange for a stock option to acquire 456,522 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
9	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	7,264	—	7,264	D	$7.99 · — to 2031-06-30	7,264 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F9) Received in exchange for a stock option to acquire 252,226 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F8) Beginning on February 22, 2021, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.
10	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	5,472	—	5,472	D	$19.45 · — to 2032-07-12	5,472 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F11) Received in exchange for a stock option to acquire 190,000 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
11	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	661	—	661	D	$10.42 · — to 2032-08-30	661 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F12) Received in exchange for a stock option to acquire 22,977 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
12	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	1,954	—	1,954	D	$10.42 · — to 2032-08-30	1,954 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F13) Received in exchange for a stock option to acquire 67,873 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F2) Immediately exercisable.
13	Derivative	Employee Stock Option (right to buy)	2023-03-20	A	A	2,090	—	2,090	D	$17.34 · — to 2033-03-19	2,090 Common Stock	(F4) Upon the closing of the Merger, each outstanding option to purchase shares of CalciMedica common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. (F15) Received in exchange for a stock option to acquire 72,589 shares of common stock of CalciMedica pursuant to the Merger Agreement. (F14) Beginning on November 22, 2022, the shares subject to the option vest in a series of forty-eight (48) successive equal monthly installments.